Submit Deal

BIOTAGE AB

HQ - Uppsala 

Summary

Biotage is a drug discovery and development, diagnostics and analytical testing solutions provider company.

Deals Overview

Total Deals4

Valued Deals4

Total Value£ 1.34 B

Avg. Deal Size£ 336 M

Market Context

Senior Management

Frederic Vanderhaegen
CEO
Tomas Blomquist
CEO and President
Andrew Kellett
CFO

Senior Management

Frederic Vanderhaegen
CEO
Tomas Blomquist
CEO and President
Andrew Kellett
CFO

Sort

20 Oct 2021|Sweden|Biotechnology

Target: ATDBIO

Bidder: BIOTAGE AB

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 45 M

Value

15 Feb 2023|United States|Biotechnology

Target: GAMMA BIOSCIENCES

Bidder: BIOTAGE AB

3 Service Providers

1 Target | 1 Bidder | 1 Vendor

5 Dealmakers

2 Target | 1 Bidder | 2 Vendor

£ 193 M

Value

15 Feb 2023|United Kingdom|Biotechnology

Target: ASTREA BIOSEPARATIONS

Bidder: BIOTAGE AB

7 Service Providers

1 Target | 3 Bidder | 3 Vendor

9 Dealmakers

1 Target | 4 Bidder | 4 Vendor

£ 196 M

Value

22 Apr 2025|Sweden|Biotechnology

Target: BIOTAGE AB

Bidder: KKR & CO

11 Service Providers

4 Target | 7 Bidder

24 Dealmakers

2 Target | 22 Bidder

£ 909 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy